Chairman of the Board, Japan Health Sciences Foundation
After the 3 speeches, the speakers will join a Panel Discussion moderated by the Session Chair.
RIKEN Drug Discovery ―Life Innovation from Japanese Academia―
Program for Drug Discovery and Medical Technology Platforms,
Introduction to RIKEN Program for Drug Discovery and Medical Technology Platforms, which was launched in 2010, aiming to promote innovations in the field of life sciences. The program ultimately aims to contribute to global human health through successful drug discovery and medical technology achievements deriving from basic research conducted by Japanese academia.
R&D for Innovative Pharmaceuticals in AIST
Vice President, Director-General for Life Science and Biotechnology,
National Institute of Advanced Industrial Science and Technology (AIST)
R&D for innovative pharmaceuticals in AIST by using multi-disciplinary approaches such as development of disease biomarkers by glyco-chain analyses and development of supporting technologies for drug discovery by nano-biotechnology, robotics and bioinformatics will be introduced.
Research and Development for Innovative Pharmaceuticals in NIBIO
National Institute of Biomedical Innovation (NIBIO)
The National Institute of Biomedical Innovation (NIBIO) has been engaged in various activities to support and promote drug discovery research in both academia and industry. Also, in close collaboration with RIKEN and AICS, we have started the preparatory work to establish the Drug Discovery Support Network.